Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 52 Weeks

15-Jun-17 - 13-Jun-18
Buy Ratio:40%


# Net Buyers:90
# Net Sellers:135

Previous 52 Weeks

16-Jun-16 - 14-Jun-17
Buy Ratio:41%
# Net Buyers:131
# Net Sellers:189
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Mylan N.V.($6.20M)$1.83B  
Catalent, Inc.($4.99M)$407.06M  
Bausch Health Companies Inc.($14.43M)$202.92M  
Relypsa Inc--$140.39M  
Biomarin Pharmaceutical Inc($11.71M)$104.41M  
New Net Buyers
CompanyNet Buy AmountChange
Eagle Pharmaceuticals, Inc.$19.41K$100.47M  
Global Blood Therapeutics, Inc.$2.31M$98.77M  
Acceleron Pharma Inc$20.56M$83.37M  
Esperion Therapeutics, Inc.$4.58M$53.79M  
Intercept Pharmaceuticals, Inc.$39.17M$49.19M  
Largest Negative Net Change
CompanyNet Buy AmountChange
Colucid Pharmaceuticals, Inc.--($713.06M)  
Kite Pharma, Inc.($698.90M)($647.36M)  
Juno Therapeutics, Inc.($222.26M)($211.05M)  
Seattle Genetics Inc /wa($13.78M)($128.05M)  
Vertex Pharmaceuticals Inc / Ma($175.38M)($98.53M)  
New Net Sellers
CompanyNet Buy AmountChange
Seattle Genetics Inc /wa($13.78M)($128.05M)  
Abbott Laboratories($38.36M)($63.33M)  
Acadia Pharmaceuticals Inc($7.25M)($40.10M)  
Alnylam Pharmaceuticals, Inc.($14.75M)($25.64M)  
Calithera Biosciences, Inc.($9.11M)($15.66M)